Tag:
Elevation Pharmaceuticals
Latest Headlines
Latest Headlines
Elevation boasts 'gold standard' IIb data for COPD therapy
Today the biotech boasted that their therapy--EP-101--had registered positive data in a Phase IIb study, positioning it as a potential new "gold standard" in nebulized treatments for the ailment.
PhRMA's COPD pipeline report spotlights blockbuster hopefuls
Anyone looking for a basic primer on experimental COPD drugs should check out PhRMA's latest compilation of new drugs in the pipeline. The big trade group found 54 COPD studies underway, which
Canaan Partners adds $200M in venture funds for life sciences
Canaan Partners is starting off 2012 with a bang. The venture fund announced it has rounded up $600 million for its new fund, with $200 million carved out for new healthcare and life sciences
Biotechs round up new venture cash for COPD, Alzheimer's programs
San Diego-based Elevation Pharmaceuticals has raked in enough venture cash to push development of its nebulized LAMA treatment for COPD—the biotech's lead drug program—right up to the
Elevation Pharma nabs $17M, recruits two key players
San Diego-based Elevation Pharmaceuticals says a successful clinical trial allowed the company to grab $17 million from its tranched Series A financing. The biotech, which is developing aerosol
